GE HealthCare Technologies (GEHC) Projected to Post Quarterly Earnings on Wednesday

GE HealthCare Technologies (NASDAQ:GEHC) is projected to announce its Q4 2025 results before the market opens on Wednesday, February 4th. Analysts expect the company to announce earnings of $1.43 per share and revenue of $5.6021 billion for the quarter. Investors are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the latest details on the call scheduled for Wednesday, February 4, 2026 at 8:30 AM ET.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.05 by $0.02. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. The firm had revenue of $5.14 billion during the quarter, compared to analyst estimates of $5.07 billion. During the same quarter last year, the business earned $1.14 EPS. The business’s revenue was up 5.8% on a year-over-year basis. On average, analysts expect GE HealthCare Technologies to post $5 EPS for the current fiscal year and $5 EPS for the next fiscal year.

GE HealthCare Technologies Price Performance

GEHC stock opened at $80.32 on Wednesday. The company has a current ratio of 1.18, a quick ratio of 0.95 and a debt-to-equity ratio of 0.83. GE HealthCare Technologies has a 12 month low of $57.65 and a 12 month high of $94.80. The stock has a market cap of $36.59 billion, a PE ratio of 16.60, a P/E/G ratio of 2.42 and a beta of 1.08. The company has a 50-day moving average price of $82.36 and a 200 day moving average price of $77.29.

GE HealthCare Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Friday, January 9th will be paid a dividend of $0.035 per share. The ex-dividend date of this dividend is Friday, January 9th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is currently 2.89%.

Institutional Investors Weigh In On GE HealthCare Technologies

Hedge funds have recently modified their holdings of the business. Norinchukin Bank The increased its holdings in GE HealthCare Technologies by 0.4% during the third quarter. Norinchukin Bank The now owns 38,913 shares of the company’s stock valued at $2,922,000 after buying an additional 149 shares during the period. Larson Financial Group LLC grew its holdings in GE HealthCare Technologies by 1.6% in the third quarter. Larson Financial Group LLC now owns 10,680 shares of the company’s stock worth $802,000 after purchasing an additional 164 shares during the last quarter. Brown Brothers Harriman & Co. increased its position in shares of GE HealthCare Technologies by 4.6% during the third quarter. Brown Brothers Harriman & Co. now owns 4,279 shares of the company’s stock worth $321,000 after purchasing an additional 189 shares in the last quarter. Towarzystwo Funduszy Inwestycyjnych PZU SA lifted its holdings in shares of GE HealthCare Technologies by 50.0% during the 3rd quarter. Towarzystwo Funduszy Inwestycyjnych PZU SA now owns 720 shares of the company’s stock valued at $54,000 after purchasing an additional 240 shares during the last quarter. Finally, Laird Norton Wetherby Wealth Management LLC lifted its holdings in shares of GE HealthCare Technologies by 4.9% during the 3rd quarter. Laird Norton Wetherby Wealth Management LLC now owns 5,131 shares of the company’s stock valued at $385,000 after purchasing an additional 241 shares during the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on GEHC shares. Citigroup raised their price target on GE HealthCare Technologies from $83.00 to $88.00 and gave the stock a “neutral” rating in a research note on Thursday, December 11th. Weiss Ratings reiterated a “hold (c+)” rating on shares of GE HealthCare Technologies in a research note on Monday, December 29th. The Goldman Sachs Group reissued a “buy” rating and set a $98.00 target price on shares of GE HealthCare Technologies in a research note on Friday, January 9th. Barclays began coverage on shares of GE HealthCare Technologies in a report on Monday, October 13th. They issued an “equal weight” rating and a $86.00 price target on the stock. Finally, BTIG Research reissued a “buy” rating and issued a $87.00 price objective on shares of GE HealthCare Technologies in a research report on Friday, November 21st. Seven research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $89.83.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.